You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 10, October 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetic Disorders
 •Neurogenetics
 •Neuromuscular diseases
 •Alert me on articles by topic

Atypical Phenotypes in Patients With Facioscapulohumeral Muscular Dystrophy 4q35 Deletion

Michael Krasnianski, MD; Katharina Eger, MD; Stephan Neudecker, MD; Sibylle Jakubiczka, PhD; Stephan Zierz, MD

Arch Neurol. 2003;60:1421-1425.

Background  Facioscapulohumeral muscular dystrophy (FSHD) is associated with a deletion on chromosome 4q35. Recent studies have shown that this deletion is found in patients with other phenotypes in addition to those with the classic Landouzy-Dejerine FSHD phenotype.

Objective  To examine patients with atypical phenotypes and an FSHD deletion on chromosome 4q35.

Design  Clinical characterization and genotype-phenotype correlation.

Setting  University hospital.

Patients  Forty-one symptomatic subjects with deletions on chromosome 4q35.

Results  We found 6 patients with atypical FSHD. Three (from a single family with FSHD) had additional symptoms of chronic progressive external ophthalmoplegia (4q35 EcoRI/BlnI fragment size, 20 kilobase [kb]), and 3 patients (1 with sporadic disease and 2 from a single family) had facial-sparing scapulohumeral dystrophy (4q35 EcoRI/BlnI fragment size, 30 and 34 kb, respectively).

Conclusions  The clinical presentations in patients with FSHD-associated short fragments on chromosome 4q35 are not restricted to the classic FSHD form, but constitute a variety of clinical manifestations. There seems to be no clear correlation between the atypical subtype and the DNA fragment size due to the deletion.


From the Department of Neurology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany (Drs Krasnianski, Eger, Neudecker, and Zierz), and the Department of Human Genetics, Otto-von-Guericke-University, Magdeburg, Germany (Dr Jakubiczka).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Significance of Beevor's sign in facioscapulohumeral dystrophy and other neuromuscular diseases
Shahrizaila and Wills
J. Neurol. Neurosurg. Psychiatry 2005;76:869-870.
ABSTRACT | FULL TEXT  

A novel autosomal recessive myopathy with external ophthalmoplegia linked to chromosome 17p13.1-p12
Lossos et al.
Brain 2005;128:42-51.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.